DJIA 17,172.68 -107.06 -0.62%
NASDAQ 4,527.69 -52.10 -1.14%
S&P 500 1,994.29 -16.11 -0.80%
market minute promo

159.83 -4.40 (-2.68%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SLXP $159.83 -2.68%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $164.16
Previous Close $164.23
Daily Range $159.25 - $164.62
52-Week Range $65.38 - $165.32
Market Cap $10.2B
P/E Ratio 190.97
Dividend (Yield) $0.00 (0.0%)
Volume 780,294
Average Daily Volume 1,650,504
Current FY EPS $2.10





Salix Pharmaceuticals, Ltd. (SLXP) Description

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract. Website:

News & Commentary Rss Feed

This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results

A long-awaited mega-merger is announced, Exelixis reminds Wall Street that its pipeline is more than a single compound, and Amgen shows flashes of what's coming down its pipeline.

Salix Pharmaceuticals, Ltd. Set To Be Acquired By Allergan, Inc.

Botox maker Allergan rejected Actavis takeover bid

Benzinga's M&A Chatter for Monday September 22, 2014

Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's Post-Market Leader Stock

Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog

Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog

Sector Update: Health-Care Shares Mixed Pre-Market

Sector Update: Health Care

Salix Secures Additional Intellectual Property Relating To Rifaximin

AstraZeneca's Constipation Drug Movantik Gets FDA Nod - Analyst Blog

3 Stocks Pushing The Health Care Sector Higher

See More SLXP News...

SLXP's Top Competitors

SLXP $159.83 (-2.68%)
Current stock: SLXP
JNJ $107.88 (-0.10%)
Current stock: JNJ
RHHBY $37.66 (0.07%)
Current stock: RHHBY
PFE $30.18 (-0.72%)
Current stock: PFE